Metabolic Dysfunction-Associated Steatohepatitis

Disease State Hub

News
Research Summaries
Resources
FDA Alerts Pearls of Wisdom From the Journal
Insights
Commentary Podcasts Q&As Videos
Interactive
Polls Quizzes Slideshows
Events & Education

Featured

Roundtable
Naim Alkhouri MD
Roundtable
Initiating Resmetirom for Patients With MASH: Recommendations on Patient Selection, Treatment Response, and Patient Monitoring
12/12/2024
Naim Alkhouri, MD; Amreen M. Dinani, MD, FRCPC; Mazen Noureddin, MD, MHSc
In this video, Naim Alkhouri MD, FAASLD moderates a roundtable discussion with Amreen M. Dinani, MD, FRCPC and Mazen Noureddin, MD, MHSc on the practical clinical applications associated with starting and...
12/12/2024
ROUNDTABLE
James Matera DO
ROUNDTABLE
Key Updates on the Treatment and Management of MASH
10/08/2024
James Matera, DO
In this video, James Matera, DO moderates a roundtable discussion with Colin Brown, MD, Kunal Gupta MD, and Lisa Jones, MA, RD that reviews the recent developments regarding the treatment and management of...
10/08/2024
FDA Alert
pills
FDA Alert
FDA Approves First Treatment for Adults With MASH, Serious Liver Disease
03/21/2024

Anthony Calabro, MA

Anthony Calabro, MA
The FDA approved resmetirom for the treatment of adults with metabolic dysfunction-associated steatohepatitis with moderate-to-advanced liver fibrosis.
03/21/2024

Interactive Features

Pop Quiz
Liver
Pop Quiz
Prevalence of NASH
03/10/2023
Test your knowledge on the prevalence of nonalcoholic steatohepatitis in the United States by taking our short pop quiz!
03/10/2023
POLL
POLL
Targeting Liver Treatments
03/01/2023
Individuals with MASH and significant liver fibrosis have a higher risk for serious liver-related outcomes compared with those with simple steatosis. Which endpoint should be a target for treatment: MASH...
03/01/2023

Clinical Insights

Roundtable
Naim Alkhouri MD
Roundtable
Initiating Resmetirom for Patients With MASH: Recommendations on Patient Selection, Treatment Response, and Patient Monitoring
12/12/2024
Naim Alkhouri, MD; Amreen M. Dinani, MD, FRCPC; Mazen Noureddin, MD, MHSc
In this video, Naim Alkhouri MD, FAASLD moderates a roundtable discussion with Amreen M. Dinani, MD, FRCPC and Mazen Noureddin, MD, MHSc on the practical clinical applications associated with starting and...
12/12/2024
ROUNDTABLE
James Matera DO
ROUNDTABLE
Key Updates on the Treatment and Management of MASH
10/08/2024
James Matera, DO
In this video, James Matera, DO moderates a roundtable discussion with Colin Brown, MD, Kunal Gupta MD, and Lisa Jones, MA, RD that reviews the recent developments regarding the treatment and management of...
10/08/2024
Video
Naim Alkhouri, MD
Video
The Relationship Between Waist Circumference, Liver Disease
03/07/2024
In this video, Dr Alkhouri discusses the relationship between waist circumference and metabolic dysfunction-associated steatotic liver disease (MASLD)/metabolic dysfunction-associated steatohepatitis,...
03/07/2024
Guest Commentary
Guest Commentary
Noninvasive Point-of-Care Examinations for Liver Disease can Enhance Patient Engagement, Improve Outcomes
05/04/2023
In this commentary, Robert G. Gish, MD, from the Hepatitis B Foundation, writes about the importance of early detection, prevention, and treatment of liver disease, as well as the role of physicians at...
05/04/2023
Liver Disease
Liver Disease
The Impact of Diet on Liver-Related Mortality in Patients With NAFLD
09/02/2022
In a recent study, researchers investigated the burden of disability based on the presence of various complications and the various potential etiologies in order to better understand trends in disability...
09/02/2022